Kit for separating and detecting tumor-derived exosome based on DNA hydrogel and application of kit
Through a DNA hydrogel-based kit, exosomes are wrapped and separated by specific aptamer and hybrid chain reaction nanostructures, the problems of exosome separation in the prior art are solved, and the problem of time and low purity of exosome separation in the prior art is achieved, and the rapid and simple The specific tumor-derived exosomes are isolated and detected, with good biological activity and applicability.
Patent Information
- Application Number
- CN202411043256.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-15
AI Technical Summary
The prior art is difficult to effectively isolate and detect exosomes from specific tumor sources, especially in complex clinical samples. The traditional method takes a long time, cumbersome operation, and the isolated exosomes are not purified, which cannot meet the external source of low-abundance tumors. Analytical requirements for secretions.
Using a DNA hydrogel-based kit, hybrid chain reaction nanostructures are formed through components such as T1 aptamer, T2 aptamer, H1, H2 and calcium ions, to wrap and separate exosomes, and to achieve rapid and simple use of manual centrifugation and fluorescence detection. specific isolation and detection.
This method can be used to separate specific tumor-derived exosomes without large instruments and equipment, and isolate exosomes with good biological activity. It is suitable for subsequent analysis and application, and is suitable for exosomes from other cell-derived exosomes. Isolation and detection.
Smart Images

Figure CN118956759A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biotechnology, and in particular relates to a kit for separating and detecting tumor-derived exosomes based on DNA hydrogel and an application thereof. Background Art
[0002] Exosomes have been widely studied because of their important role in various pathophysiological processes, especially in the occurrence and development of diseases. They are considered to be important biomarkers for disease diagnosis and treatment monitoring. However, the separation and analysis of small-sized (30-150nm) exosomes remains a challenge. Traditional exosome separation methods include ultracentrifugation, size exclusion chromatography, polymer precipitation and other methods. These methods have the disadvantages of being time-consuming, cumbersome, requiring large instruments and low purity of separated exosomes. At present, separation methods based on membrane filtration and temperature-sensitive polymers have been developed. These methods are still a challenge for the separation and analysis of specific exosome subpopulations (tumor-related exosomes). Methods for constructing immunoaffinity using antibodies and nucleic acid aptamers have also been developed for the separation and analysis of exosomes. These methods can only separate and analyze non-specific exosomes. The separation and analysis of specific exosomes from tumors is still a problem, especially under the interference of a large number of normal cell-derived exosomes in complex clinical samples. The separation and analysis of low-abundance tumor-derived exosomes is still an unmet need. Therefore, it is necessary to develop a simple and rapid method to separate and detect specific tumor-derived exosomes. Summary of the invention
[0003] The technical problem to be solved by the present invention is to overcome the deficiencies in the prior art and provide a kit for separating and detecting tumor-derived exosomes based on DNA hydrogel and its application. The kit for separating and detecting tumor-derived exosomes based on DNA hydrogel is simple to operate, does not require large-scale instruments and equipment, has good biocompatibility, can separate specific tumor-derived exosomes, and the separated exosomes have good biological activity and can be used for subsequent analysis and application. The method can also be used for the separation and analysis of exosomes from other cell sources.
[0004] In order to solve the above technical problems, the present invention provides a kit for detecting tumor-derived exosomes based on DNA hydrogel separation, comprising T1 aptamer, T2 aptamer, H1, H2, and an initiator;
[0005] The gene sequence of the T1 aptamer is aptamer1-T15-trigger1, the gene sequence of the trigger1 is shown in SEQ ID NO.1, and the aptamer1 is an aptamer sequence that specifically binds to the surface protein on tumor exosomes;
[0006] The gene sequence of the T2 aptamer is aptamer2-T15-trigger2, the gene sequence of the trigger2 is shown in SEQ ID NO.2, and the aptamer2 is an aptamer sequence that specifically binds to the surface protein on tumor exosomes;
[0007] The gene sequence of H1 is shown in SEQ ID NO.3;
[0008] The gene sequence of H2 is shown in SEQ ID NO.4;
[0009] Sodium alginate is connected to one end of the H1.
[0010] In the above-mentioned kit, further, the initiator is calcium ion.
[0011] In the above-mentioned kit, further, the concentration ratio of the T1 aptamer to the T2 aptamer is 1:1; the concentration ratio of the H1 to the H2 is 1:1.
[0012] In the above-mentioned kit, further, the concentration of the initiator is 1 mM.
[0013] The above-mentioned kit further includes EDTA, and the concentration of EDTA is 5mM.
[0014] In the above-mentioned kit, further, the T1 aptamer is CD63-T1 aptamer, and the gene sequence of the CD63-T1 aptamer is shown in SEQ ID NO.5; the T2 aptamer is EpCAM-T2 aptamer, and the gene sequence of the EpCAM-T2 aptamer is shown in SEQ ID NO.6.
[0015] Based on a general technical concept, the present invention also provides a use of the kit in preparing a kit for detecting tumor-derived exosomes.
[0016] In the above application, further, the method of the application comprises the following steps:
[0017] S1, forming a hybrid chain reaction nanostructure with alginate on the surface of the exosomes to form a complex of exosomes-hybrid chain reaction nanostructure-alginate;
[0018] S2, adding calcium ions as an initiator for hydrogel formation to encapsulate the exosomes in the DNA hydrogel;
[0019] S3. Centrifuge and detect the fluorescence signal of separated exosomes.
[0020] Based on a general technical concept, the present invention also provides a use of the kit in preparing a separation kit for detecting tumor-derived exosomes.
[0021] In the above application, further, the method of the application also includes:
[0022] S1, forming a hybrid chain reaction nanostructure with alginate on the surface of the exosomes to form a complex of exosomes-hybrid chain reaction nanostructure-alginate;
[0023] S2, adding calcium ions as an initiator for hydrogel formation to encapsulate the exosomes in the DNA hydrogel;
[0024] S3, centrifugation, and detection of the fluorescence signal of the separated exosomes;
[0025] S4. Add ethylenediaminetetraacetic acid to convert the hydrogel into a sol to release exosomes.
[0026] Compared with the prior art, the advantages of the present invention are:
[0027] (1) The present invention provides a kit for detecting tumor-derived exosomes based on DNA hydrogel separation, which overcomes the shortcomings of current exosome separation and detection that are time-consuming and labor-intensive. The hydrogel encapsulating the exosomes is separated by simple manual centrifugation and fluorescence detection.
[0028] (2) The present invention provides a kit for use in separating and detecting tumor-derived exosomes. The method is simple to operate, does not require large-scale instruments and equipment, can separate specific tumor-derived exosomes, and the separated exosomes have good biological activity and can be used for subsequent analysis and application. The method can also be used for the separation and detection of exosomes from other cell sources. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] In order to make the purpose, technical solution and advantages of the embodiments of the present invention more clear, the technical solution in the embodiments of the present invention will be clearly and completely described below in conjunction with the accompanying drawings in the embodiments of the present invention.
[0030] Figure 1 This is a schematic diagram of exosome separation in Example 1 of the present invention.
[0031] Figure 2 Schematic diagram of the covalent cross-linking of sodium alginate (Alg) and H1 in Example 1 of the present invention.
[0032] Figure 3 This is a performance characterization result diagram in Experiment 1 of the present invention.
[0033] Figure 4 This is a diagram of a manual centrifugation device for separation and detection of exosomes in Example 2 of the present invention.
[0034] Figure 5 This is the scanning electron microscope characterization and confocal imaging characterization of the DNA nano-network structure formed in Experiment 2 of the present invention.
[0035] Figure 6 This is the sensitivity investigation result of exosome detection in breast cancer cell MCF-7 in Experiment 3 of the present invention.
[0036] Figure 7 These are the results of the selective investigation of exosome detection in breast cancer cell MCF-7 in Experiment 4 of the present invention.
[0037] Figure 8 This is a bar graph of the capture efficiency and release efficiency of MCF-7 exosomes at different concentrations in Experiment 5 of the present invention.
[0038] Fig. 9 This is the NTA characterization of the capture and release efficiency of DNA hydrogel on exosomes of breast cancer cells MCF-7 in Experiment 6 of the present invention.
[0039] Fig.10 These are the results of protein activity of exosomes from breast cancer cells MCF-7 isolated by different separation methods in Experiment 7 of the present invention.
[0040] Fig.11 This is a bright field image of the cell scratch activity of exosomes from breast cancer cells MCF-7 isolated in Experiment 8 of the present invention.
[0041] Fig.12 This is the confocal imaging image of cell uptake in Experiment 8 of the present invention. DETAILED DESCRIPTION
[0042] The present invention is further described below in conjunction with specific preferred embodiments, but the protection scope of the present invention is not limited thereby.
[0043] The materials, reagents and instruments used in the following examples can all be purchased from commercial channels. The experimental methods in the following examples are all conventional methods in the art unless otherwise specified.
[0044] Table 1: Nucleotide sequence listing
[0045]
[0046]
[0047] Example
[0048] A kit for separating and detecting tumor-derived exosomes based on DNA hydrogel of the present invention comprises T1aptamer, T2aptamer, H1, H2 and an initiator.
[0049] The sequence of T1 aptamer includes: aptamer1 sequence that specifically binds to the surface protein on the exosomes of breast cancer cells MCF-7 - TTT TTT TTT TTT TTT (T15) - trigger1. The DNA sequence of trigger1 is shown in SEQ ID NO.1, specifically CGA CAT CTA ACC TGG CGT CCT TCA T.
[0050] The sequence of T2 aptamer includes: aptamer2 sequence that specifically binds to the surface protein on the exosomes of breast cancer cells MCF-7 - TTT TTT TTT TTT TTT (T15) - trigger2. The DNA sequence of trigger2 is shown in SEQ ID NO.2, specifically GAC CCT AAG CAT ACA TGC TCA CTG ACG CTA GG.
[0051] Figure 1 It is a schematic diagram of the separation and detection of exosomes in this embodiment. It can be seen from the figure that T1 aptamer and T2 aptamer are incubated at 25°C for 30 minutes to specifically bind to CD63 and EpCAM proteins on the surface of exosomes, respectively. One end of T1 aptamer and T2 aptamer extends a sequence that can trigger H1-Alg and H2 to form HCR DNA nanostructures. When Connector, H1-Alg, and H2 are present, T1 aptamer and T2 aptamer trigger H1-Alg and H2 to open the hairpin structure, forming a hybrid chain reaction DNA nanostructure (HCR) with sodium alginate side chains on the surface of exosomes. Calcium ions and sodium alginate on the HCR side chains form a hydrogel that encapsulates exosomes, and then the exosome-encapsulated hydrogel is separated from the complex matrix by a separation column and a low-speed manual centrifugation device. EDTA is added to turn the hydrogel into a sol, and the separated exosomes are released from the hydrogel. The signal of Cy3 on HCR is measured to achieve quantitative detection of exosomes.
[0052] Figure 2 Schematic diagram of covalent cross-linking of sodium alginate (Alg) and H1. Figure 2 As shown, sodium alginate and H1 are coupled by covalent cross-linking. Sodium alginate has a large number of carboxyl (-COOH) functional groups and modified amino groups (-NH2) on H1. They are covalently coupled in the presence of 1-ethyl-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) to form a sodium alginate-H1 complex (H1-Alg).
[0053] The present invention forms an HCR DNA nanostructure with alginate on the surface of the exosomes to form an exosome-HCR nanostructure-alginate complex, adds calcium ions as an initiator for hydrogel formation, wraps the exosomes in the DNA hydrogel, and separates and detects the exosomes by low-speed manual centrifugation. Then, ethylenediaminetetraacetic acid (EDTA), which binds more strongly to calcium ions, is added to convert the hydrogel into a sol to release the exosomes. The method is simple to operate, does not require large-scale instruments and equipment, can separate specific tumor-derived exosomes, and the separated exosomes have good biological activity and can be used for subsequent analysis and application. The method provides an alternative for specific exosome separation and analysis.
[0054] T1 aptamer and T2 aptamer are composed of an aptamer sequence that can specifically bind to CD63 and EpCAM proteins on the exosomes of breast cancer cells MCF-7 and a sequence that can trigger a hybridization chain reaction (HCR). In the middle is a T15 sequence that can increase the space between the two segments, reduce the steric hindrance of the aptamer in binding proteins, and make it easier to form a secondary structure and specifically bind to the target protein of the exosomes of breast cancer cells MCF-7. For exosomes from other tumors, the same effect can be achieved by simply changing the aptamer sequence that specifically recognizes exosomes.
[0055] Example 1
[0056] A kit for separating and detecting exosomes of breast cancer cell MCF-7 based on DNA hydrogel of the present invention comprises 10 μM CD63-T1 aptamer, 10 μM EpCAM-T2 aptamer, 10 μM Connector, 50 μM H1-Alg, 50 μM H2, 1 mM calcium ion and 5 mM EDTA.
[0057] Among them, CD63-T1 aptamer is an aptamer sequence that specifically binds to CD63 protein; EpCAM-T2 aptamer is an aptamer sequence that specifically binds to EpCAM protein.
[0058] Experiment 1: Performance characterization.
[0059] In order to investigate the feasibility of isolating and detecting exosomes from breast cancer cells MCF-7, the DNA nanostructures formed in the kit of Example 1 were characterized by agarose electrophoresis and UV-visible absorption spectroscopy, and the DNA nanostructures formed after cross-linking sodium alginate were characterized by agarose electrophoresis.
[0060] Figure 3The results of performance characterization. A in the figure is the agarose electrophoresis characterization diagram of the Alg-H1 complex, B is the UV-visible absorption spectrum diagram, and C is the agarose electrophoresis characterization diagram of the DNA nanostructure. It can be seen from the figure that compared with H1 without cross-linked sodium alginate (lane 1), the molecular weight of the complex after cross-linking sodium alginate is significantly increased, and the band of the complex in lane 2 appears at the back position, indicating that the H1-sodium alginate complex is formed, while the sodium alginate in lane 3 has no obvious band. The formation of the complex was further characterized by UV-visible absorption spectroscopy. Compared with the position of the maximum absorption peak of the single-chain H1 (268nm), the maximum absorption peak position of the Alg-H1 complex is blue-shifted (260nm), further indicating the successful preparation of the Alg-H1 complex.
[0061] In order to investigate the effect of the prepared Alg-H1 complex on the assembly of DNA nanostructures, the Alg-H1 complex was annealed and incubated with the remaining single strands for 90 min to form a hybrid chain reaction DNA nanostructure, which was characterized by agarose electrophoresis (C in the figure). A DNA nanostructure with a larger molecular weight was clearly formed in lane 7, while no nanostructure with a larger molecular weight was formed in the remaining lanes. The above results indicate that the Alg-H1 complex has no effect on the formation of DNA nanostructures.
[0062] Example 2
[0063] An application of the kit of Example 1 in detecting breast cancer exosomes (MCF-7 cell exosomes). The application process is shown in Figure 4 , specifically including the following steps:
[0064] (1) Forming a DNA nanostructure with alginate on the surface of exosomes to form an exosome-HCR-Alg complex. The specific steps include:
[0065] 1.1. 10 μM CD63-T1 aptamer and 10 μM EpCAM-T2 aptamer were incubated at 25°C for 30 min to specifically bind to CD63 and EpCAM proteins on the surface of exosomes, respectively.
[0066] 1.2. Add 10 μM Connector, 50 μM H1-Alg, and 50 μM H2 respectively and incubate at 25°C for 60 min. CD63-T1aptamer and EpCAM-T2 aptamer trigger H1-Alg and H2 to open the hairpin structure and form a hybrid chain reaction DNA nanostructure (exosome-HCR-Alg complex) on the surface of exosomes.
[0067] (2) 1 mM calcium ions were added as an initiator for hydrogel formation to form DNA hydrogel with sodium alginate in the exosome-HCR-Alg complex. The DNA hydrogel encapsulating the exosomes was then separated from the complex matrix by a separation column and a low-speed manual centrifugation device.
[0068] (3) 5 mM EDTA was added to the DNA hydrogel encapsulating exosomes to turn the hydrogel into a sol, and the separated exosomes were released from the hydrogel to achieve exosome separation. The signal of Cy3 on HCR was then measured to achieve quantitative detection of exosomes.
[0069] Experiment 2: Scanning electron microscopy and confocal imaging characterization of nano-DNA hydrogels.
[0070] Figure 5 Scanning electron microscopy characterization and confocal imaging characterization of the DNA hydrogel formed in step (1) of Example 2 of the present invention.
[0071] A in the figure is a scanning electron microscope characterization image, and B in the figure is a confocal imaging characterization image. It can be seen from the figure that the formed DNA hydrogel has a porous mesh nanostructure, which is more conducive to the capture of exosomes. Laser confocal microscopy was further used to characterize its morphology. Under a 100× objective lens, the Cy3 excitation light wavelength was 530nm, and the pseudo color was red. The mesh nanostructure with Cy3 red fluorescence can be seen in the figure. The results are consistent with the results of SEM, proving that the formed DNA hydrogel can be used for the separation and detection of exosomes.
[0072] Experiment 3: Investigate the sensitivity of MCF-7 exosome detection.
[0073] The kit of Example 2 was used to investigate the MCF-7 exosomes at different concentrations (1.0×10 4 particles / mL~1.0×10 11 The detection method is shown in Example 2.
[0074] Figure 6 The sensitivity test results are shown in Figure A. The fluorescence intensity changes with different concentrations of MCF-7 exosomes; Figure B is the corresponding concentration and fluorescence intensity linear relationship. It can be seen from the figure that as the concentration of exosomes increases from 1.0×10 4 particles / mL increased to 1.0×10 11 particles / mL, the corresponding fluorescence signal also gradually increased, indicating that this method showed concentration dependence in response to target exosomes. At the same time, the fluorescence intensity value showed a good linear relationship with the exosome concentration of MCF-7 cells (R 2=0.99). According to 3σ, the minimum detection limit of this method for target exosomes is 3.2×10 3 particles / mL.
[0075] Experiment 4: Investigate the specificity of MCF-7 exosome detection.
[0076] Human normal liver cells (L02), human colon cancer cells (HCT 116), neuroblastoma cells (SH-SY5Y), human non-small cell lung cancer cells (A549), human liver cancer cells (SMMC-7721) and human normal breast cells (MCF-10A) as well as mixed exosomes from all sources were selected as control groups to investigate the specificity of this method.
[0077] Figure 7 To investigate the specificity results, A in the figure is a graph showing the changes in fluorescence intensity with different cell exosomes, and B in the figure is a bar graph showing the corresponding changes in fluorescence intensity. It can be seen from the figure that the fluorescence signal generated only in the presence of MCF-7 exosomes is significantly higher than the signal of the exosomes in the control group. This indicates that the expression levels of the transmembrane protein CD63 and the specific protein EpCAM on the surface of MCF-7 exosomes are significantly higher than those of normal exosomes (MCF-10A) and other tumor cell exosomes. Based on this, this method not only has the ability to distinguish tumor exosomes from normal cell exosomes, but also has the potential to distinguish different types of tumor exosomes.
[0078] Experiment 5: Investigate the capture and release efficiency of DNA hydrogel on exosomes.
[0079] The exosomes were stained with the lipophilic membrane dye DiO. 5μM DiO was incubated with exosomes of different concentrations at 37°C for 30min, and then the unbound dye was washed away using a 100kDa ultrafiltration centrifuge tube at 8000rpm for 20min at 4°C, and then rinsed three times with PBS buffer. The excitation was excited with a laser at 480nm, and the fluorescence signal (F0) at 500-700nm was collected. The stained exosomes were used for capture and release efficiency investigation. 10μM CD63-T1 aptamer and EpCAM-T2 aptamer were added to the above-mentioned stained exosomes and incubated for 30min. Finally, 10μM Connector, 50μM H1-Alg and H2 were added to form HCR nanostructures with Alg, and then 1mM calcium ions were added to form a hydrogel. The separation of exosomes can be achieved by a simple centrifugal device.
[0080] The fluorescence signal of the separated exosomes was measured (F1). EDTA was added to the separated hydrogel to make it into a sol, the exosomes were released, and their fluorescence signal was measured (F2). The capture efficiency and release efficiency can be calculated using the following formula:
[0081] Capture efficiency = F1 / F0 × 100% (I);
[0082] Capture efficiency = F2 / F1×100% (II).
[0083] Figure 8 The bar graphs show the capture efficiency and release efficiency of MCF-7 exosomes at different concentrations. 4 particles / mL to 10 10 The capture efficiency of exosomes of particles / mL is generally around 80%, and the release efficiency is generally around 85%. Furthermore, the method of the present application has good capture efficiency and release efficiency.
[0084] Experiment 6: Investigate the accuracy of DNA hydrogel’s capture and release efficiency of breast cancer exosomes.
[0085] Nanoparticle tracer technology (NTA) was used to verify that Fig. 9 Figure 1 is the accuracy test result; Figure A is the NTA characterization of MCF-7 exosomes; Figure B is the NTA characterization of captured MCF-7 exosomes; Figure C is the NTA characterization of released MCF-7 exosomes, and Figure D is the corresponding capture and release efficiency bar graph.
[0086] As can be seen from the figure: the constructed DNA hydrogel-based method has good performance in capturing and releasing MCF-7 exosomes, and can be used for capturing and releasing MCF-7 exosomes.
[0087] Experiment 7: Investigate the activity of isolated exosome surface proteins by protein electrophoresis.
[0088] The surface proteins of exosomes isolated by three common separation methods.
[0089] The first one is the commonly used ultra-high speed centrifugation method (UC).
[0090] The second type is: a commercially available polymer precipitation exosome isolation kit (Kit).
[0091] The third is the separation method of Example 2.
[0092] The three separation methods were investigated respectively to perform protein electrophoresis on the isolated MCF-7 exosomes to characterize the surface CD63 protein and EpCAM protein content.
[0093] Fig.10The results of protein content of MCF-7 exosomes separated by different separation methods, Figure A is the electrophoresis diagram of MCF-7 exosome proteins separated by different separation methods; Figure B is the BCA protein relative quantitative diagram; Figure C is the corresponding gray value bar graph.
[0094] As can be seen from the figure: the separation method based on DNA hydrogel (Gels) has better separation performance than the separation method of the kit. The total protein of the exosomes was further quantitatively separated by the BCA method, and the results were consistent with the above, indicating that the separation method based on DNA hydrogel has good separation performance, and the separation of exosomes is more gentle and non-destructive, which can be used for subsequent research applications.
[0095] Experiment 8: Investigate the biological activity of breast cancer exosomes separated by DNA hydrogel.
[0096] In order to prove the biological activity of released MCF-7 exosomes and their potential for downstream applications, such as recognition and uptake by target cells as drug carriers, and to study the role of exosomes in tumor growth, progression and metastasis, the biological activity of isolated MCF-7 exosomes was investigated by cell scratch assay and cell uptake assay. The biological activity of isolated exosomes was verified by cell scratch assay, using MCF-7 exosomes isolated by ultrahigh-speed centrifugation as control.
[0097] Fig.11 This is a bright field image of isolated MCF-7 exosome cell scratches. It can be seen from the figure that the scratch area of 24h in all groups is smaller than that of 0h. By counting the scratch area at 0h and 24h, the exosomes separated by the two separation methods enhanced the proliferation and migration of MCF-7 cells, and the exosomes separated by DNA hydrogel had a more obvious promoting effect on cells. The above results show that the exosomes captured and released by DNA hydrogel have certain biological activity.
[0098] Next, the biological activity of MCF-7 exosomes was verified by cell uptake experiments. Fig.12 This is a confocal imaging image of isolated MCF-7 exosome cell uptake. The green fluorescence represents the DiO dye fluorescence, which is used to show the location and distribution of MCF-7 exosomes in cells, and the blue fluorescence represents the fluorescence of the cell nuclear dye Hoechst.
[0099] Fig.12 Confocal imaging of cell uptake. As can be seen from the figure: an obvious green fluorescent signal is displayed around the blue fluorescent cell nucleus, indicating that the isolated MCF-7 exosomes can enter the cells and can be taken up by MCF-7 cells, further indicating that the exosomes separated by this method have certain biological activity.
[0100] The above is only a preferred embodiment of the present invention and does not limit the present invention in any form. Although the present invention has been disclosed as above in the preferred embodiment, it is not used to limit the present invention. Any technician familiar with the art can make many possible changes and modifications to the technical solution of the present invention by using the methods and technical contents disclosed above without departing from the spirit and technical solution of the present invention, or modify it into an equivalent embodiment of equivalent changes. Therefore, any simple modification, equivalent replacement, equivalent change and modification made to the above embodiments according to the technical essence of the present invention without departing from the content of the technical solution of the present invention, still fall within the scope of protection of the technical solution of the present invention.
Claims
1. A kit for detecting tumor-derived exosomes based on DNA hydrogel separation, characterized in that: Including T1aptamer, T2 aptamer, H1, H2, initiator; The gene sequence of the T1 aptamer is aptamer-T15-trigger1, the gene sequence of the trigger1 is shown in SEQ ID NO.1, and the aptamer is an aptamer sequence that specifically binds to the surface protein on tumor exosomes; The gene sequence of the T2 aptamer is aptamer-T15-trigger2, the gene sequence of the trigger2 is shown in SEQ ID NO.2, and the aptamer sequence specifically binds to the surface protein on tumor exosomes; The gene sequence of H1 is shown in SEQ ID NO.3; The gene sequence of H2 is shown in SEQ ID NO.4; Sodium alginate is connected to one end of the H1.
2. The kit according to claim 1, characterized in that The initiator is calcium ion.
3. The kit according to claim 1, characterized in that The concentration ratio of the T1 aptamer to the T2 aptamer is 1:1; the concentration ratio of the H1 to the H2 is 1:1; and the concentration of the initiator is 1 mM.
4. The kit according to claim 1, characterized in that EDTA was also included at a concentration of 5 mM.
5. The kit according to any one of claims 1 to 4, characterized in that The T1 aptamer is CD63-T1 aptamer, and the gene sequence of the CD63-T1 aptamer is shown in SEQ ID NO.5; The T2 aptamer is EpCAM-T2 aptamer, and the gene sequence of the EpCAM-T2 aptamer is shown in SEQ ID NO.
6.
6. Use of the kit according to any one of claims 1 to 5 in preparing a kit for detecting tumor-derived exosomes.
7. The use according to claim 6, characterized in that: The method of application comprises the following steps: S1, forming a hybrid chain reaction nanostructure with alginate on the surface of the exosomes to form a complex of exosomes-hybrid chain reaction nanostructure-alginate; S2, adding calcium ions as an initiator for hydrogel formation to encapsulate the exosomes in the DNA hydrogel; S3. Centrifuge and detect the fluorescence signal of separated exosomes.
8. Use of the kit according to any one of claims 1 to 5 in preparing a separation kit for detecting tumor-derived exosomes.
9. The use according to claim 8, characterized in that The method of application also includes: S1, forming a hybrid chain reaction nanostructure with alginate on the surface of the exosomes to form a complex of exosomes-hybrid chain reaction nanostructure-alginate; S2, adding calcium ions as an initiator for hydrogel formation to encapsulate the exosomes in the DNA hydrogel; S3, centrifugation, and detection of the fluorescence signal of the separated exosomes; S4. Add ethylenediaminetetraacetic acid to convert the hydrogel into a sol to release exosomes.
Citation Information
Cited By
Ex vivo tumor tissue margin three-dimensional imaging kit based on gel in-situ capture of extracellular vesicles and application thereof
CN122833144A
